NASDAQ: KLRA · Health Care / Biotechnology: Pharmaceutical Preparations

Kailera Therapeutics Inc.

How Kailera Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.7B

Price

$13.41

P/E

-7.3

EPS (TTM)

$-1.83

Dividend yield

0.0%

52-week range

$10.00–$13.41

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources